Identification of Medicinal Products (IDMP)

Chaucer / Life Sciences / Data Driven Transformation / Identification of Medicinal Products (IDMP)

The regulation recently introduced by the EMA to support Identification of Medicinal Products (IDMP) for the Life Science industry has been talked about for some time.

We know that people are talking a lot about IDMP but at Chaucer we have looked at how we can apply our experience in serialisation, MDM, ETL processes, visualisation and Regulatory Information Management.

IDMP for us starts with a simple conversation to help support your tactical or strategic direction. There is no better time than now to start the discussion as you will want to align existing initiatives (e.g. implementation of R&D CDISC Disclosure standards) so you do not have to make changes down the road.

We look at the challenge of IDMP as a data problem.

  • Where is the data?
  • How is it stored and updated?
  • How is the standard for the data maintained and governed in the organisation?
  • How can it then be processed, aggregated, maintained and submitted to support the product life cycle?

Our Team

Some of our consultants have led projects across large Pharma Organisations (R&D, Operations, CMC) from an IT and business perspective to support the creation, storage and retrieval of data.

We have the knowledge of the IDMP standards and can educate, consult and build a roadmap, but we are looking to what supporting resources and experience we can utilise across a number of geographies and to tie it up with project management methodologies that have been proven through our clients in other industries.

As a consequence of extraordinary preparation and deep understanding you’ve helped us through an MHRA PV inspection with no major or critical findings. As importantly, you left behind a real understanding of how to prepare for inspections in future.VP Global PV and Drug Safety, Tier 2 Pharma Company

If you think we can help you to implement your project or programme strategy, please call us on:
+44 (0) 203 141 8400 in UK/Europe, or ​​​+1 713 821 1783 in the USA.

Alternatively, please send us some brief information and we can discuss things in more detail.